Efficacy and Safety of SP-8203 in Patients With Ischemic Stroke Requiring rtPA

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 178 participants.

Also called NCT04479449

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 178 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04479449
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04479449. Randomized; triple masking; primary purpose treatment. Start 2019-03-18 (actual); primary completion 2020-10-19 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of SP-8203 in Patients With Ischemic Stroke Requiring rtPA
Acronym
SP-8203-2002
Intervention (Drug)
SP-8203
Intervention (Drug)
Placebo
Lead sponsor
Shin Poong Pharmaceutical Co. Ltd. (class: industry)

Record details

Record id
cardio:ct-nct04479449
Content hash
5bf4b8bb3dcf92fc5f30123ac8858d71beef9904166c3585eb760d3b967dbba9